Skip to main content
Top

01-01-2015 | Esophageal cancer | Book chapter | Article

1. Epidemiology and Risk Factors for Esophageal Cancer

Authors: Juliana Andrici, MPhil, MBBS, Guy D. Eslick, DrPH, PhD, FACE, FFPH

Publisher: Springer International Publishing

Abstract

The epidemiology of esophageal cancer has radically changed in the last 50 years in the Western world. Changes in the predominant type of squamous cell carcinoma to adenocarcinoma, disparities between different ethnicities, and the exponential increase in incidence rates of adenocarcinoma have established esophageal cancer as a major public health problem.
Literature
1.
Curado MP, Edwards B, Shin HR, editors, et al. Cancer incidence in five continents, vol. IX, IARC Scientific Publications No. 160. IARC: Lyon; 2007. http://​globocan.​iarc.​fr/​Pages/​fact_​sheets_​cancer.​aspx. Accessed 1 Dec 2014.
2.
Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62(2):118–28.PubMedCrossRef
3.
Edgren G, Adami HO, Weiderpass E, et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–14.PubMedCrossRef
4.
Cook MB. Optimization and expansion of predictive models for Barrett’s esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial? Am J Gastroenterol. 2013;108(6):923–5.PubMedCrossRef
5.
Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014. doi:10.​1136/​gutjnl-2014-308124. [Epub ahead of print].
6.
Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.PubMedCentralPubMedCrossRef
7.
Drahos J, Wu M, Anderson WF, et al. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008. PLoS One. 2013;8(7):e67913.PubMedCentralPubMedCrossRef
8.
Kong CY, Kroep S, Curtius K, et al. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev. 2014;23(6):997–1006.PubMedCentralPubMedCrossRef
9.
Castro C, Bosetti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol. 2014;25(1):283–90.PubMedCrossRef
10.
Giri S, Pathak R, Aryal MR, et al. Incidence trend of esophageal squamous cell carcinoma: an analysis of Surveillance Epidemiology, and End Results (SEER) database. Cancer Causes Control. 2015;26(1):159–61.
11.
Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.PubMedCrossRef
12.
Jemal A, Simard EP, Xu J, et al. Selected cancers with increasing mortality rates by educational attainment in 26 states in the United States, 1993–2007. Cancer Causes Control. 2013;24(3):559–65.PubMedCrossRef
13.
De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):23–34.PubMedCrossRef
14.
Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS One. 2010;5(11):e14080.PubMedCentralPubMedCrossRef
15.
Turati F, Tramacere I, La Vecchia C, et al. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24(3):609–17.PubMedCrossRef
16.
Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872–8.PubMedCrossRef
17.
Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut. 2008;57(2):173–80.PubMedCrossRef
18.
Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002;287(15):1972–81.PubMedCrossRef
19.
Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103(3):788–97.PubMedCrossRef
20.
Sikkema M, de Jonge PJ, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(3):235–44.PubMedCrossRef
21.
Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(3):237–49.PubMedCrossRef
22.
Singh S, Manickam P, Amin AV. Incidence of esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79(6):897–909.PubMedCrossRef
23.
Jansson C, Johansson AL, Nyrén O, et al. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1754–61.PubMedCrossRef
24.
Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89(17):1277–84.PubMedCrossRef
25.
Ljung R, Drefahl S, Andersson G, et al. Socio-demographic and geographical factors in esophageal and gastric cancer mortality in Sweden. PLoS One. 2013;8(4):e62067.PubMedCentralPubMedCrossRef
26.
Zhuo X, Zhang Y, Wang Y, et al. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol). 2008;20(10):757–62.CrossRef
27.
Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res. 2008;1(5):329–38.CrossRef
28.
Narang B, Cox MR, Eslick GD. Meat consumption and risk of developing esophageal cancer: a meta-analysis. Am J Cancer Epidemiol Prev. 2013;1:36–54.
29.
Li B, Jiang G, Zhang G, et al. Intake of vegetables and fruit and risk of esophageal adenocarcinoma: a meta-analysis of observational studies. Eur J Nutr. 2014;53(7):1511–21.PubMedCrossRef
30.
Tio M, Andrici J, Cox MR, et al. Folate intake and the risk of upper gastrointestinal cancers: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2014;29(2):250–8.PubMedCrossRef
31.
Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. 2014;63(8):1229–37.PubMedCentralPubMedCrossRef
32.
Andrici J, Tio M, Eslick GD. Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer. Aliment Pharmacol Ther. 2012;36(8):708–16.PubMedCrossRef
33.
Abnet CC, Freedman ND, Kamangar F, et al. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer. 2009;100(3):551–7.PubMedCentralPubMedCrossRef
34.
Wang F, Lv ZS, Fu YK. Nonsteroidal anti-inflammatory drugs and esophageal inflammation – Barrett’s esophagus – adenocarcinoma sequence: a meta-analysis. Dis Esophagus. 2011;24(5):318–24.PubMedCrossRef
35.
Singh S, Singh AG, Singh PP, et al. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(6):620–9.PubMedCentralPubMedCrossRef
36.
Steevens J, Schouten LJ, Goldbohm RA, et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59(1):39–48.PubMedCrossRef
37.
Tramacere I, La Vecchia C, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology. 2011;22(3):344–9.
38.
Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424–33.PubMedCrossRef
39.
Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822–7.PubMedCrossRef
40.
Morita M, Kumashiro R, Kubo N, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol. 2010;15(2):126–34.PubMedCrossRef
41.
Islami F, Fedirko V, Tramacere I, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011;129(10):2473–84.PubMedCrossRef
42.
Prabhu A, Obi KO, Rubenstein JH. Systematic review with meta-analysis: race-specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma. Aliment Pharmacol Ther. 2013;38(10):1145–55.PubMedCrossRef
43.
Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.PubMedCrossRef
44.
Brown LM, Hoover R, Silverman D, et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol. 2001;153(2):114–22.PubMedCrossRef
45.
Dar NA, Shah IA, Bhat GA, et al. Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India. Cancer Sci. 2013;104(9):1231–6.PubMedCrossRef
46.
Tse G, Eslick GD. Egg consumption and risk of GI neoplasms: dose-response meta-analysis and systematic review. Eur J Nutr. 2014;53(7):1581–90.PubMedCrossRef
47.
Islami F, Ren JS, Taylor PR, et al. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer. 2009;101(9):1641–7.PubMedCentralPubMedCrossRef
48.
Zamora-Ros R, Luján-Barroso L, Bueno-de-Mesquita HB, et al. Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study. Int J Cancer. 2014;135(6):1470–9.PubMedCrossRef
49.
Tverdal A, Hjellvik V, Selmer R. Coffee intake and oral-oesophageal cancer: follow-up of 389,624 Norwegian men and women 40–45 years. Br J Cancer. 2011;105(1):157–61.PubMedCentralPubMedCrossRef
50.
Ren JS, Freedman ND, Kamangar F, et al. Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer. 2010;46(10):1873–81.PubMedCentralPubMedCrossRef
51.
Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3:3. Art. No.: CD005004. doi:10.​1002/​14651858.​CD005004.​pub2.
52.
Andrici J, Eslick GD. Maté consumption and the risk of esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2013;26(8):807–16.PubMedCrossRef
53.
Dar NA, Islami F, Bhat GA, et al. Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer. 2013;109(5):1367–72.PubMedCentralPubMedCrossRef
54.
Abnet CC, Qiao YL, Mark SD, et al. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control. 2001;12(9):847–54.PubMedCrossRef
55.
Abnet CC, Kamangar F, Islami F, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3062–8.PubMedCentralPubMedCrossRef
56.
Guha N, Boffetta P, Wünsch Filho V, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case–control studies. Am J Epidemiol. 2007;166(10):1159–73.PubMedCrossRef
57.
Hiraki A, Matsuo K, Suzuki T, Kawase T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1222–7.PubMedCrossRef
58.
Abnet CC, Kamangar F, Dawsey SM, et al. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol. 2005;40(6):681–7.PubMedCrossRef
59.
Ljung R, Martin L, Lagergren J. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden. Eur J Cancer. 2011;47(14):2128–32.PubMedCrossRef
60.
Rokkas T, Pistiolas D, Sechopoulos P, et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5(12):1413–7.PubMedCrossRef
61.
Eitzen K, Eslick GD, Cox MR. Helicobacter pylori cagA positivity-an important determinant for esophageal squamous cell carcinoma risk: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2011;26:81–2.